These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25339418)

  • 1. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
    Qiu M; Wang J; Xu Y; Ding X; Li M; Jiang F; Xu L; Yin R
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):206-12. PubMed ID: 25339418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis.
    Liu Y; Xing Z; Zhan P; Liu H; Ye W; Lv T; Song Y
    Medicine (Baltimore); 2016 Nov; 95(47):e5115. PubMed ID: 27893656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis.
    Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A
    Sci Rep; 2018 Sep; 8(1):13379. PubMed ID: 30190486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
    Pécuchet N; Zonta E; Didelot A; Combe P; Thibault C; Gibault L; Lours C; Rozenholc Y; Taly V; Laurent-Puig P; Blons H; Fabre E
    PLoS Med; 2016 Dec; 13(12):e1002199. PubMed ID: 28027313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis.
    Passiglia F; Rizzo S; Rolfo C; Galvano A; Bronte E; Incorvaia L; Listi A; Barraco N; Castiglia M; Calo V; Bazan V; Russo A
    Curr Cancer Drug Targets; 2018; 18(7):697-705. PubMed ID: 29521235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis.
    Wu Y; Liu H; Shi X; Song Y
    Lung Cancer; 2015 Jun; 88(3):246-53. PubMed ID: 25837799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
    Luo J; Shen L; Zheng D
    Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of circulating-tumor DNA analysis in non-small cell lung cancer.
    Jiang T; Ren S; Zhou C
    Lung Cancer; 2015 Nov; 90(2):128-34. PubMed ID: 26415994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer.
    Akca H; Demiray A; Yaren A; Bir F; Koseler A; Iwakawa R; Bagci G; Yokota J
    Cancer Genet; 2013 Mar; 206(3):73-80. PubMed ID: 23491080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer.
    He J; Tan W; Ma J
    Future Oncol; 2017 Apr; 13(9):787-797. PubMed ID: 28073294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What future for circulating tumor DNA? Current data and prospects in colorectal, non-small cell lung and pancreatic cancers].
    Pietrasz D; Pécuchet N; Fabre E; Blons H; Chevalier L; Taly V; Laurent-Puig P; Bachet JB
    Bull Cancer; 2016 Jan; 103(1):55-65. PubMed ID: 26790710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?
    Kim ST; Jung HY; Sung JS; Jo UH; Tanaka T; Hagiwara K; Park KH; Shin SW; Kim JS; Kim YH
    Am J Clin Oncol; 2013 Feb; 36(1):57-63. PubMed ID: 22237146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
    Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
    Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.
    Shen H; Che K; Cong L; Dong W; Zhang T; Liu Q; Du J
    Oncotarget; 2017 May; 8(22):36812-36823. PubMed ID: 28415658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
    Yu J; Kane S; Wu J; Benedettini E; Li D; Reeves C; Innocenti G; Wetzel R; Crosby K; Becker A; Ferrante M; Cheung WC; Hong X; Chirieac LR; Sholl LM; Haack H; Smith BL; Polakiewicz RD; Tan Y; Gu TL; Loda M; Zhou X; Comb MJ
    Clin Cancer Res; 2009 May; 15(9):3023-8. PubMed ID: 19366827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA.
    Zhang R; Chen B; Tong X; Wang Y; Wang C; Jin J; Tian P; Li W
    Cancer Manag Res; 2018; 10():1209-1218. PubMed ID: 29844700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis.
    Smith GD; Chadwick BE; Willmore-Payne C; Bentz JS
    J Clin Pathol; 2008 Apr; 61(4):487-93. PubMed ID: 17908804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR mutations and clinical outcomes of chemotherapy for advanced non-small cell lung cancer: a meta-analysis.
    Zhang Q; Dai HH; Dong HY; Sun CT; Yang Z; Han JQ
    Lung Cancer; 2014 Sep; 85(3):339-45. PubMed ID: 25043903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.